Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Arthralgias, fatigue, paresthesias and visceral pain: can joint hypermobility solve the puzzle? A case report.

Folci M, Capsoni F.

BMC Musculoskelet Disord. 2016 Feb 4;17:58. doi: 10.1186/s12891-016-0905-2.

2.

α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines.

Capsoni F, Ongari AM, Lonati C, Accetta R, Gatti S, Catania A.

BMC Musculoskelet Disord. 2015 Jun 21;16:154. doi: 10.1186/s12891-015-0615-1.

3.

Differential expression of interleukin-2 by anti-CD3-stimulated peripheral blood mononuclear cells in patients with psoriatic arthritis and patients with cutaneous psoriasis.

Bos F, Capsoni F, Molteni S, Raeli L, Diani M, Altomare A, Garavaglia M, Garutti C, Frigerio E, Banfi G, Altomare G, Reali E.

Clin Exp Dermatol. 2014 Apr;39(3):385-90.

PMID:
24772485
4.

The diagnosis of early psoriatic arthritis.

Altomare G, Capsoni F.

G Ital Dermatol Venereol. 2013 Oct;148(5):501-4. Review.

PMID:
24005143
5.

The protein kinase C inhibitor AEB071 (sotrastaurin) modulates migration and superoxide anion production by human neutrophils in vitro.

Capsoni F, Ongari AM, Reali E, Bosè F, Altomare GF.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):617-26.

PMID:
23058012
6.

Fibromuscular dysplasia: a rare disease that can mimic vasculitis.

Capsoni F, Poletto G, Giorgetti PL.

Rheumatol Int. 2012 Dec;32(12):4027-9. doi: 10.1007/s00296-010-1511-5. Epub 2010 May 19.

PMID:
20490807
7.

Psoriasis during interferon beta treatment for multiple sclerosis.

La Mantia L, Capsoni F.

Neurol Sci. 2010 Jun;31(3):337-9. doi: 10.1007/s10072-009-0184-x. Epub 2009 Nov 19.

PMID:
19924503
8.

Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells.

Capsoni F, Ongari AM, Reali E, Catania A.

Arthritis Res Ther. 2009;11(5):R151. doi: 10.1186/ar2827. Epub 2009 Oct 8.

9.

Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.

Giorgini A, Capsoni F, Podda M, Lleó A, Battezzati PM, Ongari AM, Selmi C, Benetti A, Malinverno F, Rossaro L, Gershwin ME, Zuin M.

Ann N Y Acad Sci. 2009 Sep;1173:847-57. doi: 10.1111/j.1749-6632.2009.04623.x.

PMID:
19758237
10.

Successful cyclosporine treatment in a case of amicrobial pustulosis associated with immunological abnormalities.

Frigerio E, Ramoni S, Franchi C, Garutti C, Garavaglia M, Spinelli M, Capsoni F, Altomare GF.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):243-6.

PMID:
19309573
11.

Clinical application of bisphosphonates in implant dentistry: histomorphometric evaluation.

Zuffetti F, Bianchi F, Volpi R, Trisi P, Del Fabbro M, Capelli M, Galli F, Capsoni F, Testori T.

Int J Periodontics Restorative Dent. 2009 Feb;29(1):31-9.

PMID:
19244880
12.

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study.

Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero MT, Bergia R, Caramaschi P, Biasi D, Capsoni F, Montaguti L, Ruffini R, Brucato A, Picillo U, Fanelli V, Riccieri V, Piccoli A, Valesini G, Doria A, Meroni PL, Tincani A.

Ann Rheum Dis. 2009 Mar;68(3):397-9. doi: 10.1136/ard.2008.096669. Epub 2008 Sep 23.

PMID:
18812393
13.

Effect of Efalizumab on neutrophil and monocyte functions in patients with psoriasis.

Capsoni F, Ongari AM, Frigerio E, Taglioni M, Altomare GF.

Int J Immunopathol Pharmacol. 2008 Apr-Jun;21(2):437-45.

14.

[Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].

Capsoni F.

Reumatismo. 2008 Jan-Mar;60(1):6-13. Review. Italian.

15.

The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophils.

Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A.

Peptides. 2007 Oct;28(10):2016-22. Epub 2007 Aug 7.

PMID:
17850921
16.

Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

Capsoni F, Longhi M, Weinstein R.

Arthritis Res Ther. 2006;8(5):219. Review.

17.

Drug-induced lupus erythematosus.

Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A.

Autoimmunity. 2005 Nov;38(7):507-18. Review. Retraction in: Autoimmunity. 2008 Apr;41(3):241.

PMID:
16373256
18.

Primary and secondary autoimmune neutropenia.

Capsoni F, Sarzi-Puttini P, Zanella A.

Arthritis Res Ther. 2005;7(5):208-14. Epub 2005 Aug 31. Review.

19.

Osteoarthritis of the spine.

Sarzi-Puttini P, Atzeni F, Fumagalli M, Capsoni F, Carrabba M.

Semin Arthritis Rheum. 2005 Jun;34(6 Suppl 2):38-43. Review. No abstract available.

PMID:
16206956
20.

Successful treatment of resistant Behçet's disease with etanercept.

Atzeni F, Sarzi-Puttini P, Capsoni F, Mecchia M, Marrazza MG, Carrabba M.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):729. No abstract available.

PMID:
16173263
21.

Autoimmunity and anti-TNF-alpha agents.

Atzeni F, Turiel M, Capsoni F, Doria A, Meroni P, Sarzi-Puttini P.

Ann N Y Acad Sci. 2005 Jun;1051:559-69. Review.

PMID:
16126996
22.

Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.

Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F.

Autoimmun Rev. 2005 Mar;4(3):144-52. Review.

PMID:
15823500
23.

Thyroid acropachy: an unusual rheumatic manifestation of Graves' disease.

Capsoni F, Minonzio F, Sarzi-Puttini P, Atzeni F, Ambrosi B.

Clin Exp Rheumatol. 2005 Jan-Feb;23(1):125-6. No abstract available.

PMID:
15789906
24.

Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.

Capsoni F, Sarzi-Puttini P, Atzeni F, Minonzio F, Bonara P, Doria A, Carrabba M.

Arthritis Res Ther. 2005;7(2):R250-5. Epub 2005 Jan 10.

25.

Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?

Rizzi M, Sarzi-Puttini P, Atzeni F, Capsoni F, Andreoli A, Pecis M, Colombo S, Carrabba M, Sergi M.

J Rheumatol. 2004 Jun;31(6):1193-9.

PMID:
15170935
26.

CD69 expression on neutrophils from patients with rheumatoid arthritis.

Atzeni F, Del Papa N, Sarzi-Puttini P, Bertolazzi F, Minonzio F, Capsoni F.

Clin Exp Rheumatol. 2004 May-Jun;22(3):331-4.

PMID:
15144128
27.

Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A.

Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6):759-62. Review.

PMID:
14740456
28.

Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha.

Atzeni F, Schena M, Ongari AM, Carrabba M, Bonara P, Minonzio F, Capsoni F.

Cell Immunol. 2002 Nov;220(1):20-9.

PMID:
12718936
29.

Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease.

Conte D, Fraquelli M, Capsoni F, Giacca M, Zentilin L, Bardella MT.

J Interferon Cytokine Res. 1999 Jul;19(7):705-10.

PMID:
10454340
30.

Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis.

Gianni C, Cerri A, Capsoni F, Ongari AM, Rossini P, Crosti C.

Eur J Dermatol. 1999 Jul-Aug;9(5):390-2.

PMID:
10417445
31.

Development of phagocytic function of cultured human monocytes is regulated by cell surface IL-10.

Capsoni F, Minonzio F, Mariani C, Ongari AM, Bonara P, Fiorelli G.

Cell Immunol. 1998 Oct 10;189(1):51-9.

PMID:
9758694
32.

Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils.

Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C.

Scand J Immunol. 1997 Mar;45(3):269-75.

33.

Amicrobial pustular dermatosis of cutaneous folds associated with autoimmune disorders: a new entity?

Marzano AV, Capsoni F, Berti E, Gasparini G, Bottelli S, Caputo R.

Dermatology. 1996;193(2):88-93.

PMID:
8884141
34.

The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro.

Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM.

Peptides. 1996;17(4):675-9.

PMID:
8804079
35.

IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma.

Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C.

J Leukoc Biol. 1995 Sep;58(3):351-8.

PMID:
7665991
36.

Abnormal neutrophil chemotaxis in bone marrow transplant patients correlates with impaired 31D8 monoclonal antibody binding.

Capsoni F, Minonzio F, Carbonelli V, Ongari AM, Mocellin MC, Soligo D, Annaloro C, Della Volpe A, Lambertenghi Dliliers G.

Haematologica. 1995 Mar-Apr;80(2):123-9.

37.

Fc receptors expression and function in mononuclear phagocytes from AIDS patients: modulation by IFN-gamma.

Capsoni F, Minonzio F, Ongari AM, Bonara P, Pinto G, Carbonelli V, Lazzarin A, Zanussi C.

Scand J Immunol. 1994 Jan;39(1):45-50.

PMID:
8290892
38.

Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects.

Capsoni F, Minonzio F, Ongari AM, Colombo G, Rizzardi GP, Bonara P, D'Arminio-Monforte A, Zanussi C.

Clin Exp Immunol. 1992 Nov;90(2):175-80.

39.

Membrane expression and function of complement receptors CR1 and CR3 on neutrophils from HIV-infected subjects: modulation by rTNF-alpha and rGM-CSF.

Capsoni F, Minonzio F, Colombo G, Ongari AM, Bonara P, Rizzardi GP, Lazzarin A, Zanussi C.

Scand J Immunol. 1992 Oct;36(4):541-6.

PMID:
1411300
40.

Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human neutrophils.

Capsoni F, Minonzio F, Ongari AM, Girardello R, Zanussi C.

Pharmacol Res. 1992 Sep;26 Suppl 2:172-3. No abstract available.

PMID:
1409296
41.

Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF.

Capsoni F, Minonzio F, Ongari AM, Rizzardi GP, Lazzarin A, Zanussi C.

Clin Immunol Immunopathol. 1992 Feb;62(2):176-82.

PMID:
1730155
42.

Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.

Meroni PL, Capsoni F, Borghi MO, Barcellini W, Minonzio F, Ongari AM, Fain C, Hu C, Brambilla G, Pettenati C, et al.

Infection. 1992;20 Suppl 1:S61-3.

PMID:
1526681
43.

Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach.

Foa P, Iurlo A, Saglio G, Guerrasio A, Capsoni F, Maiolo AT.

Br J Haematol. 1991 Jun;78(2):286-8. No abstract available.

PMID:
2064971
44.

Immunostimulation of neutrophil phagocytic function by RU41740 (Biostim) in elderly subjects.

Minonzio F, Ongari AM, Palmieri R, Bochicchio D, Guidi G, Capsoni F.

Allergol Immunopathol (Madr). 1991 Mar-Apr;19(2):58-62.

PMID:
1772105
45.

The effect of cytokines on human neutrophil Fc receptor-mediated phagocytosis.

Capsoni F, Bonara P, Minonzio F, Ongari AM, Colombo G, Rizzardi GP, Zanussi C.

J Clin Lab Immunol. 1991 Mar;34(3):115-24.

PMID:
1667943
46.

Abnormal Neutrophil Chemotaxis after Successful Bone Marrow Transplantation.

Capsoni F, Minonzio F, Ongari AM, Soligo D, Luksch R, Mozzana R, Volpe AD, Deliliers GL.

Leuk Lymphoma. 1991;4(5-6):335-41. doi: 10.3109/10428199109068083.

PMID:
27467665
47.

Increased expression of C3b and C3bi receptors on human neutrophils and monocytes induced by a glycoprotein extract from Klebsiella pneumoniae (RU41740).

Capsoni F, Minonzio F, Ongari AM, Bonara P, Guidi G, Zanussi C.

Int J Immunopharmacol. 1991;13(2-3):227-33.

PMID:
1830041
48.

Polycythemia vera terminating in chronic neutrophilic leukemia: report of a case.

Iurlo A, Foa P, Maiolo AT, Luksch R, Capsoni F, Polli EE.

Am J Hematol. 1990 Oct;35(2):139-40. No abstract available.

PMID:
2399908
49.

Clinical and laboratory findings in a new case of leukocyte adhesion deficiency.

Capsoni F, Soligo D, Minonzio F, Ongari AM, Polli N, Traversari K, Biolchini A, Timoncini G, Delia D.

Haematologica. 1990 Mar-Apr;75(2):117-24.

PMID:
2358202
50.

A new simplified single-filter assay for 'in vitro' evaluation of chemotaxis of 51Cr-labeled polymorphonuclear leukocytes.

Capsoni F, Minonzio F, Ongari AM, Zanussi C.

J Immunol Methods. 1989 Jun 2;120(1):125-31.

PMID:
2732473

Supplemental Content

Loading ...
Support Center